Home ETF List About

Portfolio Holdings Detail for ISIN IE00BD8KRH84
Stock Name / FundiShares Core S&P 500 UCITS ETF GBP Hedged (Dist)
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity Type
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerGSPX.LS(GBP) CXE
ETF TickerGSPX(GBP) Euronext Amsterdam

Holdings detail for TECH

Stock NameBio-Techne Corp
TickerTECH(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS09073M1045
LEI54930073RLKQ51TILZ35

Show aggregate TECH holdings

News associated with TECH

Royal Bank Of Canada Upgrades Bio-Techne (NASDAQ:TECH) to “Moderate Buy”
Bio-Techne (NASDAQ:TECH – Get Free Report) was upgraded by equities research analysts at Royal Bank Of Canada from a “hold” rating to a “moderate buy” rating in a research note issued on Wednesday,Zacks.com reports. Several other analysts have also recently issued reports on TECH. UBS Group lowered their target price on shares of Bio-Techne from […] - 2025-09-05 05:36:53
Bio-Techne Corp (NASDAQ:TECH) Shares Acquired by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. lifted its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,511,260 shares of the biotechnology company’s stock after buying an additional 45,570 shares during the quarter. […] - 2025-08-13 05:12:55
How The Pieces Add Up: TCAF Headed For $40
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-29 10:39:29
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Cwm LLC
Cwm LLC cut its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 6.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,927 shares of the biotechnology company’s stock after selling 786 shares during the quarter. Cwm LLC’s holdings in Bio-Techne […] - 2025-07-24 04:47:00
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Signaturefd LLC
Signaturefd LLC decreased its holdings in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 9.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,690 shares of the biotechnology company’s stock after selling 293 shares during the quarter. Signaturefd LLC’s holdings in Bio-Techne were […] - 2025-07-21 05:43:00
Mutual of America Capital Management LLC Has $3.25 Million Stock Holdings in Bio-Techne Corp (NASDAQ:TECH)
Mutual of America Capital Management LLC raised its holdings in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 29.8% in the 1st quarter, HoldingsChannel reports. The fund owned 55,493 shares of the biotechnology company’s stock after acquiring an additional 12,740 shares during the period. Mutual of America Capital Management LLC’s holdings in Bio-Techne were worth $3,254,000 […] - 2025-07-18 05:16:49
Bio-Techne Corp (NASDAQ:TECH) Shares Bought by Xponance Inc.
Xponance Inc. increased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 21,540 shares of the biotechnology company’s stock after purchasing an additional 619 shares during the period. Xponance […] - 2025-07-16 06:24:53
Cerity Partners LLC Grows Position in Bio-Techne Corp (NASDAQ:TECH)
Cerity Partners LLC raised its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 20.1% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 132,742 shares of the biotechnology company’s stock after purchasing an additional 22,259 shares during the quarter. Cerity Partners LLC’s holdings in Bio-Techne were worth $7,783,000 at the end […] - 2025-07-16 05:38:08
DekaBank Deutsche Girozentrale Sells 261 Shares of Bio-Techne Corp (NASDAQ:TECH)
DekaBank Deutsche Girozentrale lowered its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 1.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,926 shares of the biotechnology company’s stock after selling 261 shares during the quarter. DekaBank Deutsche […] - 2025-07-14 05:34:48
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. lessened its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 5.1% during the first quarter, HoldingsChannel reports. The fund owned 4,960 shares of the biotechnology company’s stock after selling 269 shares during the period. Vontobel Holding Ltd.’s holdings in Bio-Techne were worth $291,000 at the end of the most […] - 2025-07-09 05:02:49
GAMMA Investing LLC Lowers Stake in Bio-Techne Corp (NASDAQ:TECH)
GAMMA Investing LLC reduced its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 38.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,795 shares of the biotechnology company’s stock after selling 1,101 shares during the quarter. GAMMA Investing LLC’s holdings in […] - 2025-07-07 04:17:11
Bio-Techne Corp (NASDAQ:TECH) Shares Purchased by Janney Montgomery Scott LLC
Janney Montgomery Scott LLC raised its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 4.6% during the 1st quarter, Holdings Channel reports. The firm owned 11,210 shares of the biotechnology company’s stock after acquiring an additional 490 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Bio-Techne were worth $657,000 at the end […] - 2025-07-02 05:43:07
Bio-Techne Corp (NASDAQ:TECH) Shares Purchased by Diversified Trust Co
Diversified Trust Co grew its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 10.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,824 shares of the biotechnology company’s stock after buying an additional 1,260 shares during the quarter. […] - 2025-06-30 05:10:55
Bessemer Group Inc. Sells 61,323 Shares of Bio-Techne Corp (NASDAQ:TECH)
Bessemer Group Inc. decreased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 75.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,748 shares of the biotechnology company’s stock after selling 61,323 shares during the quarter. Bessemer […] - 2025-06-30 04:38:49
Chevy Chase Trust Holdings LLC Sells 2,582 Shares of Bio-Techne Corp (NASDAQ:TECH)
Chevy Chase Trust Holdings LLC cut its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 82,909 shares of the biotechnology company’s stock after selling 2,582 shares during the quarter. Chevy Chase Trust […] - 2025-06-27 05:12:48
Retirement Systems of Alabama Sells 430 Shares of Bio-Techne Corp (NASDAQ:TECH)
Retirement Systems of Alabama lessened its stake in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 1.2% in the first quarter, HoldingsChannel reports. The firm owned 33,972 shares of the biotechnology company’s stock after selling 430 shares during the period. Retirement Systems of Alabama’s holdings in Bio-Techne were worth $1,992,000 at the end of the most […] - 2025-06-26 06:06:47
Bio-Techne Corp (NASDAQ:TECH) Shares Acquired by Oppenheimer Asset Management Inc.
Oppenheimer Asset Management Inc. increased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 4.6% in the first quarter, Holdings Channel reports. The firm owned 67,166 shares of the biotechnology company’s stock after acquiring an additional 2,929 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Bio-Techne were worth $3,938,000 at […] - 2025-06-26 05:16:55
Bio-Techne Corp (NASDAQ:TECH) Shares Bought by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lifted its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 21.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,803 shares of the biotechnology company’s stock after buying an additional 490 shares during the quarter. Exchange […] - 2025-06-24 04:36:51
CX Institutional Invests $27,000 in Bio-Techne Corp (NASDAQ:TECH)
CX Institutional acquired a new position in Bio-Techne Corp (NASDAQ:TECH – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 459 shares of the biotechnology company’s stock, valued at approximately $27,000. Several other large investors also […] - 2025-06-19 04:52:57
Bio-Techne Corp (NASDAQ:TECH) Receives Consensus Rating of “Hold” from Brokerages
Bio-Techne Corp (NASDAQ:TECH – Get Free Report) has earned an average recommendation of “Hold” from the eleven analysts that are presently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price objective among analysts […] - 2025-06-18 06:12:46
Mn Services Vermogensbeheer B.V. Sells 6,200 Shares of Bio-Techne Corp (NASDAQ:TECH)
Mn Services Vermogensbeheer B.V. trimmed its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 9.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 56,200 shares of the biotechnology company’s stock after selling 6,200 shares during the quarter. Mn Services […] - 2025-06-18 05:32:53
Bio-Techne (NASDAQ:TECH) Cut to Hold at Wall Street Zen
Wall Street Zen lowered shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a hold rating in a research note issued to investors on Sunday. Several other analysts have also commented on the stock. Citigroup lowered their price target on shares of Bio-Techne from $80.00 to $70.00 and set a “neutral” rating […] - 2025-06-09 03:44:45
Rhumbline Advisers Increases Position in Bio-Techne Co. (NASDAQ:TECH)
Rhumbline Advisers lifted its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 15.1% during the first quarter, Holdings Channel.com reports. The institutional investor owned 300,474 shares of the biotechnology company’s stock after acquiring an additional 39,345 shares during the quarter. Rhumbline Advisers’ holdings in Bio-Techne were worth $17,617,000 as of its most recent filing […] - 2025-06-08 05:35:05
Squarepoint Ops LLC Buys 4,816 Shares of Bio-Techne Co. (NASDAQ:TECH)
Squarepoint Ops LLC boosted its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 113.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,060 shares of the biotechnology company’s stock after buying an additional 4,816 shares during […] - 2025-06-03 05:06:58
Universal Beteiligungs und Servicegesellschaft mbH Invests $4.08 Million in Bio-Techne Co. (NASDAQ:TECH)
Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 56,666 shares of the biotechnology company’s stock, valued at approximately $4,082,000. Other hedge funds and other institutional investors […] - 2025-06-02 05:36:54
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Two Sigma Advisers LP
Two Sigma Advisers LP trimmed its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,900 shares of the biotechnology company’s stock after selling 900 shares during the quarter. Two Sigma Advisers […] - 2025-06-01 05:44:50
How The Parts Add Up: XLV Headed For $158
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-26 08:22:41
Cetera Investment Advisers Decreases Position in Bio-Techne Co. (NASDAQ:TECH)
Cetera Investment Advisers lessened its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 19,857 shares of the biotechnology company’s stock after selling 887 shares during the quarter. Cetera Investment Advisers’ holdings in Bio-Techne were worth $1,430,000 at the end of the most recent […] - 2025-05-22 04:52:55
Bank of America Corp DE Sells 303,523 Shares of Bio-Techne Co. (NASDAQ:TECH)
Bank of America Corp DE cut its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 37.0% during the 4th quarter, Holdings Channel reports. The fund owned 516,549 shares of the biotechnology company’s stock after selling 303,523 shares during the period. Bank of America Corp DE’s holdings in Bio-Techne were worth $37,207,000 as of its […] - 2025-05-16 05:31:04
Mercer Global Advisors Inc. ADV Reduces Stake in Bio-Techne Co. (NASDAQ:TECH)
Mercer Global Advisors Inc. ADV decreased its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 15.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 4,028 shares of the biotechnology company’s stock after selling 751 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in Bio-Techne were worth $290,000 at the […] - 2025-05-16 04:49:06

iShares Core S&P 500 UCITS ETF GBP Hedged (Dist) TECH holdings

DateNumber of TECH Shares HeldBase Market Value of TECH SharesLocal Market Value of TECH SharesChange in TECH Shares HeldChange in TECH Base ValueCurrent Price per TECH Share HeldPrevious Price per TECH Share Held
2025-09-18 (Thursday)372,654TECH holding increased by 22USD 19,746,935TECH holding increased by 548934USD 19,746,93522USD 548,934 USD 52.99 USD 51.52
2025-09-17 (Wednesday)372,632TECH holding increased by 198USD 19,198,001TECH holding decreased by -86632USD 19,198,001198USD -86,632 USD 51.52 USD 51.78
2025-09-16 (Tuesday)372,434TECH holding increased by 88USD 19,284,633TECH holding increased by 64132USD 19,284,63388USD 64,132 USD 51.78 USD 51.62
2025-09-15 (Monday)372,346USD 19,220,501USD 19,220,501
2025-09-12 (Friday)372,126USD 19,075,179USD 19,075,179
2025-09-11 (Thursday)372,060TECH holding increased by 110USD 19,797,313TECH holding increased by 842741USD 19,797,313110USD 842,741 USD 53.21 USD 50.96
2025-09-10 (Wednesday)371,950USD 18,954,572TECH holding decreased by -1205118USD 18,954,5720USD -1,205,118 USD 50.96 USD 54.2
2025-09-09 (Tuesday)371,950TECH holding increased by 110USD 20,159,690TECH holding increased by 39428USD 20,159,690110USD 39,428 USD 54.2 USD 54.11
2025-09-08 (Monday)371,840USD 20,120,262USD 20,120,262
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TECH by Blackrock for IE00BD8KRH84

Show aggregate share trades of TECH

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-18BUY22 52.990* 59.80
2025-09-17BUY198 51.520* 59.85
2025-09-16BUY88 51.780* 59.90
2025-09-11BUY110 53.210* 59.94
2025-09-09BUY110 54.200* 60.03
2025-08-12BUY66 52.830* 60.08
2025-08-11BUY198 50.150* 60.14
2025-08-08BUY506 50.420* 60.20
2025-08-07BUY66 50.150* 60.26
2025-08-01BUY396 54.890* 60.30
2025-07-31BUY22 54.730* 60.33
2025-07-30BUY176 57.710* 60.35
2025-07-29BUY22 57.870* 60.37
2025-07-14BUY176 52.620* 60.42
2025-07-11SELL-44 54.140* 60.46 Profit of 2,660 on sale
2025-07-10BUY176 54.410* 60.50
2025-07-09BUY176 52.590* 60.55
2025-07-08BUY132 52.680* 60.60
2025-07-07SELL-506 51.535* 60.66 Profit of 30,696 on sale
2025-07-02SELL-638 53.180* 60.82 Profit of 38,801 on sale
2025-06-30BUY374 51.450* 60.88
2025-06-27BUY198 51.840* 60.94
2025-06-25SELL-44 51.890* 61.07 Profit of 2,687 on sale
2025-06-24BUY22 50.000* 61.14
2025-06-23BUY572 49.300* 61.23
2025-06-20SELL-66 49.890* 61.31 Profit of 4,046 on sale
2025-06-18SELL-132 50.130* 61.47 Profit of 8,115 on sale
2025-06-13SELL-66 50.520* 61.64 Profit of 4,068 on sale
2025-06-12BUY66 51.530* 61.72
2025-06-11BUY88 51.540* 61.80
2025-06-06SELL-110 48.690* 62.07 Profit of 6,827 on sale
2025-06-05SELL-66 48.310* 62.17 Profit of 4,104 on sale
2025-06-04SELL-88 49.850* 62.27 Profit of 5,480 on sale
2025-06-02BUY286 48.610* 62.49
2025-05-30SELL-63 48.400* 62.60 Profit of 3,944 on sale
2025-05-29BUY22 48.330* 62.71
2025-05-28SELL-22 47.930* 62.83 Profit of 1,382 on sale
2025-05-27BUY242 48.690* 62.95
2025-05-23SELL-440 46.780* 63.22 Profit of 27,817 on sale
2025-05-22SELL-484 47.320* 63.35 Profit of 30,663 on sale
2025-05-21BUY22 46.660* 63.50
2025-05-20BUY176 49.530* 63.61
2025-05-19BUY638 49.280* 63.74
2025-05-16BUY594 49.150* 63.86
2025-05-15BUY484 48.240* 64.00
2025-05-14BUY440 47.860* 64.14
2025-05-13SELL-88 51.610* 64.26 Profit of 5,655 on sale
2025-05-12BUY22 53.900* 64.35
2025-05-09BUY66 49.940* 64.48
2025-05-08SELL-638 49.780* 64.62 Profit of 41,225 on sale
2025-05-07SELL-308 48.750* 64.76 Profit of 19,947 on sale
2025-05-06BUY770 47.720* 64.92
2025-05-02BUY66 50.490* 65.20
2025-05-01SELL-110 49.630* 65.35 Profit of 7,189 on sale
2025-04-30BUY66 50.350* 65.50
2025-04-29BUY154 50.500* 65.65
2025-04-28BUY328 50.250* 65.80
2025-04-25BUY308 50.240* 65.95
2025-04-24BUY88 50.780* 66.11
2025-04-23BUY242 50.160* 66.27
2025-04-22SELL-134 49.080* 66.45 Profit of 8,904 on sale
2025-04-17BUY44 48.100* 67.04
2025-04-16BUY88 49.975* 67.22
2025-04-15BUY440 51.070* 67.40
2025-04-11BUY550 50.720* 67.75
2025-04-10BUY902 49.260* 67.96
2025-04-09BUY176 54.070* 68.11
2025-04-08BUY462 48.810* 68.34
2025-04-07BUY527 52.310* 68.52
2025-04-04SELL-1,320 51.720* 68.72 Profit of 90,710 on sale
2025-04-02BUY154 58.380* 68.84
2025-03-31SELL-594 58.630* 69.11 Profit of 41,050 on sale
2025-03-28SELL-374 58.730* 69.24 Profit of 25,894 on sale
2025-03-27SELL-110 59.950* 69.35 Profit of 7,629 on sale
2025-03-26BUY198 59.380* 69.48
2025-03-25SELL-264 59.980* 69.60 Profit of 18,374 on sale
2025-03-24BUY154 61.070* 69.71
2025-03-21BUY264 60.610* 69.83
2025-03-19BUY42 60.890* 70.08
2025-03-18SELL-396 62.830* 70.18 Profit of 27,791 on sale
2025-03-17BUY418 62.580* 70.28
2025-03-14BUY374 62.160* 70.40
2025-03-13BUY1,846 59.880* 70.55
2025-03-12BUY880 60.235* 70.70
2025-03-11BUY352 58.470* 70.88
2025-03-07BUY208 64.370* 71.10
2025-03-06SELL-198 63.390* 71.22 Profit of 14,101 on sale
2025-03-05BUY684 62.200* 71.36
2025-03-04BUY132 60.120* 71.54
2025-03-03BUY594 61.190* 71.70
2025-02-28SELL-154 61.750* 71.87 Profit of 11,067 on sale
2025-02-27BUY22 61.230* 72.04
2025-02-26SELL-44 64.150* 72.18 Profit of 3,176 on sale
2025-02-25BUY418 64.220* 72.31
2025-02-21BUY308 64.920* 72.57
2025-02-20BUY176 65.490* 72.70
2025-02-19BUY44 65.800* 72.82
2025-02-18BUY110 65.290* 72.97
2025-02-13BUY374 66.770* 73.37
2025-02-12BUY132 67.440* 73.49
2025-02-11SELL-44 68.340* 73.60 Profit of 3,238 on sale
2025-02-07SELL-176 72.810* 73.70 Profit of 12,970 on sale
2025-02-06BUY88 75.010* 73.67
2025-02-04BUY770 72.550* 73.66
2025-02-03BUY286 72.050* 73.69
2025-01-31BUY66 73.550* 73.70
2025-01-30BUY44 72.760* 73.72
2025-01-29BUY418 71.830* 73.77
2025-01-28BUY198 74.600* 73.75
2025-01-27BUY308 76.450* 73.67
2025-01-24BUY198 77.050* 73.58
2025-01-23BUY572 76.910* 73.49
2025-01-22BUY374 78.710* 73.33
2024-12-10BUY154 77.120* 73.22
2024-12-09BUY176 77.400* 73.09
2024-12-06BUY264 74.510* 73.04
2024-12-05BUY66 73.890* 73.01
2024-12-04BUY242 75.890* 72.91
2024-12-03BUY776 75.050* 72.84
2024-12-02BUY65 76.020* 72.72
2024-11-29BUY506 75.360* 72.62
2024-11-27BUY594 75.380* 72.39
2024-11-26BUY1,276 74.870* 72.28
2024-11-25BUY1,320 74.390* 72.18
2024-11-22BUY1,540 71.280* 72.23
2024-11-21BUY242 71.050* 72.28
2024-11-20BUY220 68.720* 72.47
2024-11-19BUY198 66.370* 72.81
2024-11-18BUY1,782 66.860* 73.16
2024-11-12BUY616 74.410* 73.08
2024-11-11BUY418 74.690* 72.98
2024-11-08BUY316 75.960* 72.76
2024-11-07BUY1,958 76.420* 72.48
2024-11-06BUY594 75.830* 72.20
2024-11-05BUY876 77.620* 71.71
2024-11-04BUY154 75.900* 71.29
2024-11-01BUY352 75.310* 70.84
2024-10-31BUY88 73.750* 70.48
2024-10-30BUY218 76.020* 69.69
2024-10-29BUY528 70.740* 69.51
2024-10-28SELL-154 70.380* 69.34 Profit of 10,678 on sale
2024-10-25BUY264 68.680* 69.50
2024-10-24BUY176 68.370* 69.88
2024-10-23BUY220 69.340* 70.15
2024-10-22BUY566 69.950* 70.36
2024-10-21BUY616 70.360* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TECH

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19651,35111,081870,85674.8%
2025-09-18364,7260635,89757.4%
2025-09-17271,704109711,34538.2%
2025-09-16359,43201,639,77821.9%
2025-09-15279,70130759,61936.8%
2025-09-12389,4061,558859,94245.3%
2025-09-11291,39729720,35140.5%
2025-09-10623,442211,428,22043.7%
2025-09-09496,5733171,091,06945.5%
2025-09-08324,673215797,10140.7%
2025-09-05300,894351736,45040.9%
2025-09-04298,14550849,32735.1%
2025-09-03396,4460721,67254.9%
2025-09-02157,8040635,17724.8%
2025-08-29267,6043,210620,56843.1%
2025-08-28552,63101,621,66434.1%
2025-08-27319,849448770,75941.5%
2025-08-26501,622768647,13777.5%
2025-08-25403,253775980,20941.1%
2025-08-22345,299759513,18267.3%
2025-08-21321,8404618,18452.1%
2025-08-20340,4275602,03456.5%
2025-08-19355,2340523,53767.9%
2025-08-18257,2510489,73252.5%
2025-08-15172,7352321,97653.6%
2025-08-14267,327265566,98647.1%
2025-08-13301,96036655,81446.0%
2025-08-12336,42393800,31842.0%
2025-08-11335,295637799,43341.9%
2025-08-08425,18121,371853,69549.8%
2025-08-07562,06246,8941,314,23842.8%
2025-08-061,493,78312,2823,400,01843.9%
2025-08-05325,3055,603950,69834.2%
2025-08-04295,3211,870616,19947.9%
2025-08-01382,01610,466684,12755.8%
2025-07-31403,7771,690959,80042.1%
2025-07-30313,8576,379528,86459.3%
2025-07-29438,3262,402761,35057.6%
2025-07-28682,9256,9001,041,30065.6%
2025-07-25615,59726,3711,044,88258.9%
2025-07-241,073,71263,0372,073,18551.8%
2025-07-23529,3193,7241,012,04152.3%
2025-07-22346,5822,688608,36257.0%
2025-07-21871,04541,362,95163.9%
2025-07-18384,0621,700787,47848.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.